Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 40 years Drugs has been the definitive journal of drugs and therapeutics, providing independent and crucial information authored by leading international clinicians and researchers. Our prestigious and truly international Honorary Editorial Board ensures content of the highest quality to support clinical decision-making. Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.
通过阅读世界上最受尊敬的权威药物信息来源，了解治疗学的最新发展。40多年来， 《药物》一直是药物和治疗学的权威期刊，提供由国际领先临床医生和研究人员撰写的独立和关键信息。我们享有盛誉的真正国际化的荣誉编辑委员会确保提供最高质量的内容，以支持临床决策。通过严格和全面的同行评审评估计划，药物提供详细和客观的分析，涵盖所有疾病领域的新的和既定的药物疗法的全谱。
Pretomanid: First Approval
来源期刊：DrugsDOI：10.1007/s40265-019-01207-9
Entrectinib: First Global Approval
来源期刊：DrugsDOI：10.1007/s40265-019-01177-y
Gilteritinib: First Global Approval
来源期刊：DrugsDOI：10.1007/s40265-019-1062-3
Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety
来源期刊：DrugsDOI：10.1007/s40265-019-01069-1
Erdafitinib: First Global Approval
来源期刊：DrugsDOI：10.1007/s40265-019-01142-9
Upadacitinib: First Approval
来源期刊：DrugsDOI：10.1007/s40265-019-01211-z
Rho-Associated Kinase Inhibitors: Evolving Strategies in Glaucoma Treatment
来源期刊：DrugsDOI：10.1007/s40265-019-01130-z
Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
来源期刊：DrugsDOI：10.1007/s40265-019-01095-z
Triamcinolone Acetonide Extended-Release: A Review in Osteoarthritis Pain of the Knee
来源期刊：DrugsDOI：10.1007/s40265-019-01083-3
Lenvatinib: A Review in Hepatocellular Carcinoma
来源期刊：DrugsDOI：10.1007/s40265-019-01116-x
24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
来源期刊：DrugsDOI：10.1007/s40265-019-01248-0
Brolucizumab: First Approval
来源期刊：DrugsDOI：10.1007/s40265-019-01231-9
Sotagliflozin: First Global Approval
来源期刊：DrugsDOI：10.1007/s40265-019-01146-5
Tofacitinib: A Review in Psoriatic Arthritis
来源期刊：DrugsDOI：10.1007/s40265-019-01091-3
Clinical Overview of Enfortumab Vedotin in the Management of Locally Advanced or Metastatic Urothelial Carcinoma
来源期刊：DrugsDOI：10.1007/s40265-019-01241-7
Targeting EGFR and RAS/RAF Signaling in the Treatment of Metastatic Colorectal Cancer: From Current Treatment Strategies to Future Perspectives
来源期刊：DrugsDOI：10.1007/s40265-019-01113-0
Nutritional Psychiatry: From Concept to the Clinic
来源期刊：DrugsDOI：10.1007/s40265-019-01134-9
Emicizumab: A Review in Haemophilia A
来源期刊：DrugsDOI：10.1007/s40265-019-01200-2
Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)
来源期刊：DrugsDOI：10.1007/s40265-019-01125-w
Lasmiditan: First Approval
来源期刊：DrugsDOI：10.1007/s40265-019-01225-7
Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review
来源期刊：DrugsDOI：10.1007/s40265-019-01173-2
Relugolix: First Global Approval
来源期刊：DrugsDOI：10.1007/s40265-019-01105-0
A Pharmacological Approach to Managing Inflammatory Bowel Disease During Conception, Pregnancy and Breastfeeding: Biologic and Oral Small Molecule Therapy
来源期刊：DrugsDOI：10.1007/s40265-019-01141-w
Current Concepts and Future Approaches in the Treatment of Cutaneous Lupus Erythematosus: A Comprehensive Review
来源期刊：DrugsDOI：10.1007/s40265-019-01151-8
As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?
来源期刊：DrugsDOI：10.1007/s40265-019-01202-0
Recent Clinical Advances in Pharmacotherapy for Levodopa-Induced Dyskinesia
来源期刊：DrugsDOI：10.1007/s40265-019-01170-5
Glycopyrronium/Formoterol: A Review in COPD
来源期刊：DrugsDOI：10.1007/s40265-019-01186-x
Immunotherapy Against Gliomas: is the Breakthrough Near?
来源期刊：DrugsDOI：10.1007/s40265-019-01203-z
Perioperative Pain Management in Morbid Obesity
来源期刊：DrugsDOI：10.1007/s40265-019-01156-3
Costimulation Blockade in Kidney Transplant Recipients
来源期刊：DrugsDOI：10.1007/s40265-019-01226-6
Sotagliflozin: A Review in Type 1 Diabetes
来源期刊：DrugsDOI：10.1007/s40265-019-01230-w
Poly (ADP-ribose) Polymerase Inhibition in Patients with Breast Cancer and BRCA 1 and 2 Mutations
来源期刊：DrugsDOI：10.1007/s40265-019-01235-5
Correction to: Mirogabalin: First Global Approval
来源期刊：DrugsDOI：10.1007/s40265-019-01082-4
Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
来源期刊：DrugsDOI：10.1007/s40265-019-1056-1
Correction to: Polatuzumab Vedotin: First Global Approval
来源期刊：DrugsDOI：10.1007/s40265-019-01214-w
Lusutrombopag: A Review in Thrombocytopenia in Patients with Chronic Liver Disease Prior to a Scheduled Procedure
来源期刊：DrugsDOI：10.1007/s40265-019-01197-8
Correction to: Benefit:Risk Profile of Budesonide in Obstructive Airways Disease
来源期刊：DrugsDOI：10.1007/s40265-019-01220-y
Immune Checkpoint Inhibition in Non-metastatic Non-small Cell Lung Cancer: Chance for Cure?
来源期刊：DrugsDOI：10.1007/s40265-019-01222-w
Distinct Profiles on Subjective and Objective Adherence Measures in Patients Prescribed Antidepressants
来源期刊：DrugsDOI：10.1007/s40265-019-01107-y
Correction to: Triamcinolone Aceonide Extended-Release: A Review in Osteoarthritis Pain of the Knee
来源期刊：DrugsDOI：10.1007/s40265-019-01109-w
Correction to: Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
来源期刊：DrugsDOI：10.1007/s40265-019-01111-2
Lanadelumab: A Review in Hereditary Angioedema
来源期刊：DrugsDOI：10.1007/s40265-019-01206-w
Correction to: Eravacycline: A Review in Complicated Intra-Abdominal Infections
来源期刊：DrugsDOI：10.1007/s40265-019-01117-w
Correction to: Tiotropium/Olodaterol: A Review in COPD
来源期刊：DrugsDOI：10.1007/s40265-019-01172-3
Correction to: Damoctocog Alfa Pegol: A Review in Haemophilia A
来源期刊：DrugsDOI：10.1007/s40265-019-01190-1
Acknowledgement to Referees
来源期刊：DrugsDOI：10.1007/s40265-019-01228-4
Correction to: Dapagliflozin: A Review in Type 2 Diabetes
来源期刊：DrugsDOI：10.1007/s40265-019-01239-1
Correction to: Revefenacin: First Global Approval
来源期刊：DrugsDOI：10.1007/s40265-019-01106-z
Correction to: Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
来源期刊：DrugsDOI：10.1007/s40265-019-01237-3
Correction to: Dapagliflozin: A Review in Type 1 Diabetes
来源期刊：DrugsDOI：10.1007/s40265-019-01238-2
